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639REPLY: Transradial PCI in Women:
Zeroing in on CrossoversWe thank Drs. Chugh and Chugh for their interest
in our work (1) and for their comments. We agree
that access failure remains a limitation of trans-
radial intervention (TRI). As demonstrated in
SAFE-PCI for Women (Study of Access Site for
Enhancement of PCI for Women) trial, radial artery
spasm (RAS) is a major contributor to access site
crossover from radial to femoral. Women generally
have smaller radial arteries, and as the authors
suggest, arterial-sheath size mismatch might cause
RAS. Our protocol did not recommend sizes for
sheaths/catheters, nor did we routinely collect this
information, limiting our ability to explore this
hypothesis in our female population. Data suggest
that most U.S. operators use 5-F or 6-F sheaths for
diagnostic catheterization and 6-F sheaths for cor-
onary intervention (2). More slender equipment
might reduce RAS in women. However, our access
site crossover rate was consistent with that from
the RIVAL (Radial versus Femoral Access for Coro-
nary Intervention) trial, which studied a predomi-
nantly male population (3), suggesting that factors
other than arterial diameter contribute to access
site failure. We have demonstrated that a radial
learning curve exists (4), and variables such as
operator experience, catheter manipulation, multi-
ple arterial punctures, catheter exchanges, and use
of sedation/vasodilator therapy can all impact RAS
and crossover rates.
The authors propose using pre-procedural ultra-
sound to aid in access site decisions. Although not
routinely used in the United States and not included
in the SAFE-PCI for Women trial protocol, pre-
procedural ultrasound may provide valuable infor-
mation using relatively inexpensive, portable, and
noninvasive technology. Theoretically, ultrasound
might also reduce access-related trauma. However,
arterial size is dynamic and is affected by variables
such as the degree of patient sympathetic tone and
use of intra-arterial vasodilators. The timing of use
of imaging and ultrasound-based triaging of patients
to access site strategy should account for these fac-
tors. Furthermore, the risks/beneﬁts of recommend-
ing a “femoral ﬁrst” strategy to avoid risk of radial
access failure should be weighed carefully against
the added bleeding risk associated with femoral ac-
cess. For example, in obese, short females with small
radial arteries, one might still attempt TRI ﬁrst.
Further understanding of the correlation between
radial artery size, spasm, and access failure should
be pursued before routine use of ultrasound toguide access decisions. The use of imaging for pre-
emptive crossover risk stratiﬁcation and to optimize
contemporary TRI should also be systematically
investigated in future studies.*Connie N. Hess, MD, MHS
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2277–86.Safety and Feasibility
of Transradial
Catheterization in
Breast Cancer Survivors
A 2-Center International ExperienceThe technical feasibility of transradial access (TRA) in
breast cancer survivors is usually not a concern; even
so, the perceived fear of lymphedema, both on the
part of the survivor and medical staff, is the limiting
factor. Cardiac catheterization and percutaneous cor-
onary intervention using TRA is associated with lower
rates of vascular and bleeding complications (1–3).
However, relegating breast cancer survivors to only
femoral access denies these beneﬁts of TRA to a large
group of predominantly female patients. Therefore,
the aim of this report is to describe the safety and
feasibility of TRA in patients with prior ipsilateral
breast cancer undergoing cardiac catheterization.
We retrospectively analyzed all breast cancer pa-
tients who underwent coronary catheterizations over
a 4-year (2009 to 2013) period from 2 academic,
